Listen to the latest episode of the ASBMB's science policy podcast with Public Affairs Director Benjamin Corb.

Find all of the Pipettes & Politics episodes on Soundcloud, or subscribe wherever you get your podcasts.


Remote study sections

The coronavirus pandemic has forced federal agencies to move study sections to virtual settings, allowing reviews to continue while also allowing reviewers to follow federal guidance restricting travel and personal interactions.

In an effort to measure and understand the impact that remote peer review might have on science (positive or negative) the ASBMB encourages you to take a moment and share your thoughts and experiences regarding online study sections.

A biochemistry professor and two students navigate the COVID-19 pandemic

When Ursinus College offered a choice between on-campus classes or teaching and learning from home this semester, every faculty member and student was empowered to take the path that was right for them.

A second pathway into cells for SARS-CoV-2

Two neuroscientists write that a new understanding of the neuropilin-1 protein could speed vaccine research

SARS-CoV-2 infection can block pain, opening up unexpected new possibilities for research into pain relief medication

Most accounts to date have focused on how the virus invades cells via the ACE2 protein on the surface of many cells. But recent studies suggest there is another route that enables it to infect the nervous system.

Older people like President Trump are at more risk from COVID-19 because of how the immune system ages

Through the end of September, 79% of COVID-19 deaths in the U.S. were in patients over 65. Monocytes from older individuals produce less interferon in response to viral infections.

Pandemic snarls research administration

With data collection slowed and grant applications way up, the pandemic is disrupting the complex, slow-moving NIH funding system. Federal officials and university grant administrators are working to help researchers keep things moving.

AeroNabs promise powerful, inhalable protection against COVID-19

As the world awaits vaccines to bring the COVID-19 pandemic under control, UC San Francisco scientists have devised a novel approach to halting the spread of SARS-CoV-2, the virus that causes the disease.

Why hydroxychloroquine and chloroquine don't block coronavirus infection of human lung cells

Scientists in Germany tested the malaria drugs on various cell types and found they can block coronavirus infection in kidney cells from the African green monkey but don’t inhibit the virus in human lung cells.

The color of COVID

In a summer dominated by COVID-19 and protests against racial injustice, there are growing demands that drugmakers and investigators ensure that vaccine trials reflect the entire community.

Developing an effective COVID-19 vaccine

Our bodies have two main types of T cells. Together they can help us fend off this virus

What are the advantages of an mRNA vaccine for COVID-19?

They’re easier to manufacture than traditional vaccines, but scientifically their history is checkered

NIH project homes in on COVID racial disparities

Amid a wavering federal response that has allowed staggering levels of disease to sweep the country, the All of Us program is a potential bright spot.

Resources from the ASBMB


COVID-19 resources and guidance from funding agencies

See our list of guidance and resources from the NSF, NIH, DOE and others.


Online teaching: Practices and resources

A collection of resources for instructors in biochemistry, molecular biology and related fields as they make a transition to remote learning.


Slipping past the proofreader

The virus family that causes SARS, MERS and COVID-19 has an unusual ability to evade treatment. Can new drug candidates overcome it?

Virtual event

COVID-19 interruptions to NIH research

Understanding the funding implications and relief options of the recently passed CARES Act for the scientific community.

Virtual event

Shaping the Narrative: Effective science communication in the COVID-19 era

A panel discussion about how scientists can use their credibility and critical thinking to cut through the noise and guide the national COVID-19 dialogue.

Other resources

COVID-19 resources for librarians, campuses and health professionals
Access to coronavirus research, textbooks, text and data mining, and clinical information from Elsevier.

Sharing, discovering and citing COVID-19 data and code
A webinar from the NIH.

Open-access data and computational resources to address COVID-19
NIH curated list of links to data sources.

Virtual NIH activities for trainees outside the NIH
Resources from the NIH Office of Intramural Training & Education, including online workshops.

TED Connects
Daily conversations with TED talkers.

Resources from the Council of Graduate Schools for navigating the COVID-19 pandemic

Discussions on the biomedical workforce in the time of COVID-19
A series of discussions hosted by Rescuing Biomedical Research.

Journal of Biological Chemistry


JBC's coronavirus virtual issue presents a retrospective collection of content on coronavirus entry, proteases and host interactions to help researchers build more quickly toward therapeutic endpoints against SARS-CoV-2 and future strains.

See also...
The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus